DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers

British Journal of Cancer

Volumn 80, Issue 12, 1999, Pages 1982-1986

  Iwase, H ^a   Omoto, Y ^a   Iwata, H ^a   Toyama, T ^a   Hara, Y ^a   Ando, Y ^a   Ito, Y ^a   Fujii, Y ^a   Kobayashi, S ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Breast cancer; DNA methylation; Hormone resistance; Oestrogen receptor

Indexed keywords

ESTROGEN RECEPTOR; RESTRICTION ENDONUCLEASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; SOUTHERN BLOTTING;

BREAST NEOPLASMS; DNA METHYLATION; ESTROGEN RECEPTOR ALPHA; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RESTRICTION MAPPING; SITE-SPECIFIC DNA METHYLTRANSFERASE (CYTOSINE-SPECIFIC); TATA BOX;

EID: 0032802881     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690631     Document Type: Article

References (20)

1. Ahuja N, Mohan AL, Li Q, Stolker JM, Herman JG, Hamilton SR, Baylin SB and Issa JP (1997) Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res 57: 3370-3374
2. Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP (1998) Alterations in DNA methylation; a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196
3. Chen Z, Ko A, Yang J and Jordan VC (1998) Methylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells. Br J Cancer 77: 181-185
4. Falette NS, Fuqua SAW, Chamness GC, Cheah MS, Greene GL and McGuire WL (1990) Estrogen receptor gene methylation in human breast tumors. Cancer Res 50: 3974-3978
5. Ferguson AT, Lapidus RG, Baylin SB and Davidson NE (1995) Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res 55: 2279-2283
6. Ferguson AT, Vertino PM, Spitzner JR, Baylin SB, Muller MT and Davidson NE (1997) Role of estrogen receptor gene demethylation and DNA methyltransferase. DNA adduct formation in 5-aza-2′deoxycytidine-induced cytotoxicity in human breast cancer cells. J Biol Chem 272: 32260-32266
7. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguygen T, Beart RW, Tornout JM and Jones PA (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene-silencing. Cancer Res 55: 4531-4535
8. Grandien K, Backdahl M, Ljunggren O, Gustafsson JA and Berkenstam A (1995) Estrogen target tissue determines alternative promoter utilization of the human estrogen receptor gene in osteoblasts and tumor cell lines. Endocrinology 136: 2223-2229
9. Hayashi S, Imai K, Suga K, Kurihara T, Higashi Y and Nakachi K (1997) Two promoters in expression of estrogen receptor messenger RNA in human breast cancer. Carcinogenesis 18:(3) 459-464.
10. Hennig G, Behrens J, Truss M, Frisch S, Reichmann E and Birchmeier W (1995) Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogen 11: 475-484
11. Iwase H, Greenman JM, Barnes DM, Bobrow L, Hodgson S and Mathew CG (1995) Loss of heterozygosity of the estrogen receptor gene in breast cancer. Br J Cancer 71: 448-450
12. Iwase H, Greenman JM, Barns DM, Hodgson S, Bobrow L and Mathew CG (1996) Sequence variants of the estrogen receptor (ER) gene found in brest cancer patients with ER negative and progesterone receptor positive tumors. Cancer Lett 108: 179-184
13. Johnston SR, Saccani Jotti G, Smith IE, Salter J, Newby J, Coppen M, Ebbs SR and Dowsett M (1995) Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Res 55: 3331-3338
14. Karnik PS, Kulkarni S, Liu XP, Budd GT and Bukowski RM (1994) Estrogen receptor mutations in tamoxifen resistant breast cancer. Cancer Res 53: 349-353
15. Katzenellenbogen BS, Montano MM, Ekena K, Herman ME and McInerney EM (1997) Antiestrogens; mechanisms of action and resistance in breast cancer. Breast Cancer Res Treat 44: 23-38.
16. Lapidus RG, Nass SJ, Butash KA, Parl FF, Weitzman SA, Graff JG, Herman JG and Davidson NK (1998) Mapping of ER CpG island methylation by methylation-specific polymerase chain reaction. Cancer Res 58: 2515-2519.
17. McGuire WJ, Chamness GC and Fuqua SAW (1991) Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 5: 1571-1577
18. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB and Davidson NE (1994) Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 54: 2552-2525
19. Roodi N, Bailey LR, Kao WY, Verrier CS, Yee CJ, Dupont WD and Parl FF (1995) Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst 87: 446-451
20. Watts CK, Handel ML and King RJ (1992) Oestrogen receptor gene structure and function in breast cancer. J Steroid Biochem Mol Biol 41: 529-536